Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Mar 08, 2022 8:00 AM - Mar 09, 2022 5:00 PM

(US Eastern Standard Time)

Advertising and Promotion Regulatory Affairs Conference

ADPROMO 2022 HAS GONE VIRTUAL! #AdPromo22 is now a fully virtual event. Use code ADPROMO2022 by March 7 to save $150 for this discounted rate, and join us from the comfort of your home or office. Register today!

Session 8: OPDP Meet and Greet

Session Chair(s)

Fadwa  Almanakly, PharmD

Fadwa Almanakly, PharmD

Vice President & Head, Advertising and Promotion, Regulatory Affairs Americas

Bayer Pharmaceuticals, United States

Micheline  Awad, MBA

Micheline Awad, MBA

Sr. Director, Regulatory Advertising, Promotion, and Labeling

Day One Biopharmaceuticals, United States

This session will feature FDA staff members from the Office of Prescription Drug Promotion (OPDP), the Advertising and Promotional Labeling Branch (APLB), and the Regulatory Policy & Guidance Staff in the Office of Product Evaluation and Quality participating in a meet and greet opportunity with conference attendees. Staff members include reviewers, members of leadership, policy analysts and regulatory counsel.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the reviewer or TL for a number of OPDP, APLB or CDRH therapeutic dockets
  • Identify the diversity of educational backgrounds and professional experiences among FDA staff members
  • Efficiently communicate with the reviewer or TL for a therapeutic docket

Speaker(s)

Matthew  Falter, PharmD, RPh

Speaker

Matthew Falter, PharmD, RPh

FDA, United States

Deputy Division Director, DAPR2/OPDP

Sapna  Shah, PharmD

Moderator

Sapna Shah, PharmD

FDA, United States

Regulatory Review Officer, Division of Advertising and Promotion 1, OPDP, CDER

Susannah  O'Donnell, MPH, RAC

Speaker

Susannah O'Donnell, MPH, RAC

FDA, United States

Team Leader, Division of Advertising and Promotion Review 1

Nazia  Fatima, PharmD, MBA

Speaker

Nazia Fatima, PharmD, MBA

Sunovion, United States

Associate Director Global Regulatory Affiars

Kathleen  David, BSN

Speaker

Kathleen David, BSN

FDA, United States

Division Director, Division of Promotion Policy, Research, and Operations, OPDP

Amy  Muhlberg, PhD

Speaker

Amy Muhlberg, PhD

FDA, United States

Deputy Director, OPDP’s Division of Promotion Policy, Research and Operations

Jennifer  Chen, PharmD, MBA, RPh

Speaker

Jennifer Chen, PharmD, MBA, RPh

FDA, United States

Regulatory Review Officer, Division of Advertising and Promotion 1

Deborah  Wolf, JD

Speaker

Deborah Wolf, JD

FDA, United States

Regulatory Counsel, OPEQ , Regulatory Policy, CDRH

Lisa  Stockbridge, PhD

Speaker

Lisa Stockbridge, PhD

FDA, United States

Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER

Oluchi  Elekwachi, PharmD, MPH

Speaker

Oluchi Elekwachi, PharmD, MPH

FDA, United States

Program Coordinator

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.